BEACON Pharma Ltd Launched First Global Generic of Crizotinib

BEACON pharmaceuticals Ltd. (BPL), one of Bangladesh’s leading generic pharmaceutical companies, announced the launch of ‘Crizotinib’ internationally for the treatment of metastatic Non-Small Cell  Lung Cancer  under the brand name ‘Crizonix’.Crizonix is the 1st global generic of Crizotinib. The product has been approved by FDA  and has been recommended as a first-line treatment  for both ALK [...]